VIKING GLOBAL INVESTORS LP 13D and 13G filings for Roivant Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 4:31 pm Sale |
2024-09-30 | 13G | Roivant Sciences Ltd. ROIV |
VIKING GLOBAL INVESTORS LP | 54,099,066 7.300% |
-15,269,895![]() (-22.01%) |
Filing |
2024-02-14 10:20 am Sale |
2023-12-31 | 13G | Roivant Sciences Ltd. ROIV |
VIKING GLOBAL INVESTORS LP | 69,368,961 8.600% |
-5,869,739![]() (-7.80%) |
Filing |
2023-06-26 5:05 pm Sale |
2023-06-22 | 13G | Roivant Sciences Ltd. ROIV |
VIKING GLOBAL INVESTORS LP | 75,238,700 9.900% |
-13,000,000![]() (-14.73%) |
Filing |
2022-02-14 5:01 pm Purchase |
2021-12-31 | 13G | Roivant Sciences Ltd. ROIV |
VIKING GLOBAL INVESTORS LP | 88,238,700 12.800% |
88,238,700![]() (New Position) |
Filing |